Home
    About US
    Market Activity
    World Indices
    Market Watch
    Coustumer Service
    Learning Center
    Economic Event
• About US
• Why Consider Us
• Learn More About Us
• Premium Plan
• Market OverView
• Market Momentum
• Market Indices
• Volume Leader
• Parcentage Advance
• Percentage Decline
• Commodity
• Symbole lookup
• Quotes & Charts
• India : BSE
• Japan : NIKKEI
• UK : FTSE
• Breakout Stock
• Stock For Portfolio
• Penny Stock
• ETF
• Before The Bell
• World Indices
• Market Outlook
• Real Time Message Board
• Week Ahead
• Contect Us
• Feedback
• Change Password
• Relative Strength Index (RSI)
• Commodity Channel Index (CCI)
• Chaikin Money Flow (CMF)
• On Balance Volume (OBV)
• Price Rate of Change (ROC)
• Stochastic Oscillator (STO)
• % Price Oscillators (PPO)
• Moving Average (MA)
• Economic Event
• MSNBC
• CBS Marketwatch
• Yahoo Finance
• Forbes
• CNN
About US
Why Consider Us
Learn More About Us
Login
Premium Plan
Join Now
Tell a Friend
Help
Feedback
Contact Us
Member Profile
Forgot Password
Change Password
Stock Trading
Stock Trading Strategy
Technical Strategy
Breakout Stocks
Penny Stocks
401K Plan
401K Guide
401K Strategy
Learning Center
• Relative Strength Index-RSI
• Commodity Channel Index-CCI
• Chaikin Money Flow -CMF
• On Balance Volume - OBV
• Price Rate of Change - ROC
• Stochastic Oscillator-STO
• % Price Oscillators-PPO
Affiliate Program
Resources
Disclaimer
advertising
Technically up Trend Stocks for Portfolio | Day | Swing Trading with support | resistance | stock research
CBST
CUBIST PHARMACEUTICALS INC COM
Sector
Biotechnology & Drugs
Recommendations
Buy
Buy Near
23.54
Stop Loss
17.82
Posted Date
11/2/2008 12:00:00 AM
First Resistance
25.55
Second Resistance
26.77
Third Resistance
First Support
23.34
Second Support
17.82
Comments
11/2/2008 9:05:00 PM
Biotechnology company Cubist Pharmaceuticals Inc.com (CBST) stock given a breakout on 10/31/08 with good volume again many technical indicators also have given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. Cubist Pharmaceuticals Inc.com (CBST) announced on 10/16/08 its third-quarter profit jumped 40 percent and Revenue increased 41 percent. Cubist Pharmaceuticals Inc.com (CBST) is a drug discovery company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. Cubist Pharmaceuticals Inc.com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $23.54
Top 5 Mid-Caps for Nov. 20 (at TheStreet.com)
(Wed, 19 Nov 2008 23:09:04 Etc/GMT)
FDA panel: Theravance antibiotic safe, effective (AP)
Federal health advisers on Wednesday said an antibiotic developed by Theravance appears safe and effective for fighting "superbug" bacteria, despite potential risks for pregnant women.(Wed, 19 Nov 2008 23:07:59 Etc/GMT)
[$$] Recession or Not, We Still Need Drugs (at RealMoney by TheStreet.com)
(Mon, 17 Nov 2008 21:09:50 Etc/GMT)
Top 5 Fast-Growth Stocks for Nov. 17 (at TheStreet.com)
(Mon, 17 Nov 2008 11:59:30 Etc/GMT)
CUBIST PHARMACEUTICALS INC Financials (EDGAR Online Financials)
(Sat, 15 Nov 2008 14:04:17 Etc/GMT)
PETS
PETMED EXPRESS INC COM
Sector
Retail (Drugs)
Recommendations
Buy
Buy Near
16.00
Stop Loss
14.20
Posted Date
11/2/2008 12:00:00 AM
First Resistance
17.72
Second Resistance
19.50
Third Resistance
First Support
15.97
Second Support
14.20
Comments
11/2/2008 9:06:46 PM
PetMed Express Inc.com (PETS) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. PetMed Express Inc.com (PETS) announced on 10/20/08 its fiscal second-quarter profit climbed 29 percent PetMed Express Inc.com (PETS) is a pet-medication delivery company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. PetMed Express Inc.com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $16.00
Retail Industry (Zacks.com)
(Tue, 18 Nov 2008 21:27:53 Etc/GMT)
These Stocks Are Still Growing (at Motley Fool)
(Tue, 18 Nov 2008 20:39:40 Etc/GMT)
Seven Investment Candidates from the Forbes 'Best Small Companies' List (at Seeking Alpha)
(Mon, 17 Nov 2008 10:07:07 Etc/GMT)
Top 5 Small-Caps for Nov. 14 (at TheStreet.com)
(Fri, 14 Nov 2008 11:59:51 Etc/GMT)
Stock to Watch: PETS (at Seeking Alpha)
(Fri, 14 Nov 2008 10:14:09 Etc/GMT)
WSBC
WESBANCO INC COM
Sector
Financial
Recommendations
Buy
Buy Near
27.18
Stop Loss
25.46
Posted Date
11/2/2008 12:00:00 AM
First Resistance
28.90
Second Resistance
30.00
Third Resistance
31.45
First Support
25.46
Second Support
22.56
Comments
11/2/2008 9:07:49 PM
WesBanco, Inc. com (WSBC) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. WesBanco, Inc. com (WSBC) announced on 10/21/08 its net income increased 17.9% during the third quarter of 2008 WesBanco, Inc. com (WSBC) is a multi-state bank holding company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. WesBanco, Inc. com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $27.18
WESBANCO INC Financials (EDGAR Online Financials)
(Thu, 13 Nov 2008 14:04:54 Etc/GMT)
WESBANCO INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
(Thu, 6 Nov 2008 22:13:25 Etc/GMT)
WesBanco Inc upgraded by Janney Mntgmy Scott (Briefing.com)
(Wed, 22 Oct 2008 14:21:20 Etc/GMT)
WESBANCO INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)
(Tue, 21 Oct 2008 21:19:44 Etc/GMT)
WesBanco Announces Results for the Third Quarter and Nine Months of 2008 (PR Newswire)
Paul M. Limbert, President and Chief Executive Officer of WesBanco, Inc. , a Wheeling, West Virginia based multi-state bank holding company, today announced earnings for the third quarter and year-to-date periods ended September 30, 2008.(Tue, 21 Oct 2008 20:51:00 Etc/GMT)
AMED
AMEDISYS INC COM
Sector
Healthcare
Recommendations
Buy
Buy Near
55.13
Stop Loss
46.55
Posted Date
11/2/2008 12:00:00 AM
First Resistance
65.08
Second Resistance
67.29
Third Resistance
First Support
55.03
Second Support
46.55
Comments
11/2/2008 9:08:49 PM
Amedisys Inc. com (AMED) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. Amedisys Inc. com (AMED) announced on 10/28/08 its profit grew 16 percent in the third quarter, and revenue jumped 78 percent. The company reported stronger admissions growth, and it was operating 150 more health agencies than a year earlier and also raised its full-year estimates, predicting greater profit and revenue Amedisys Inc. com (AMED) is a Home nursing company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. Amedisys Inc. com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $55.13
Zacks #1 Rank Additions for Friday (Zacks.com)
(Fri, 14 Nov 2008 11:48:40 Etc/GMT)
AMEDISYS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)
(Wed, 12 Nov 2008 11:21:43 Etc/GMT)
Stock Plays for Healthcare's Shifting Landscape (at CNBC)
(Tue, 11 Nov 2008 19:55:28 Etc/GMT)
Zacks #1 Rank Additions for Monday (Zacks.com)
(Mon, 10 Nov 2008 11:50:24 Etc/GMT)
Zacks #1 Rank Additions for Monday (Zacks.com)
(Mon, 3 Nov 2008 12:09:04 Etc/GMT)
EBS
EMERGENT BIOSOLUTIONS INC COM
Sector
Biotech & Drugs
Recommendations
Buy
Buy Near
Stop Loss
Posted Date
11/2/2008 12:00:00 AM
First Resistance
18.19
Second Resistance
Third Resistance
First Support
16.11
Second Support
14.60
Comments
11/2/2008 9:09:46 PM
Emergent BioSolutions Inc. com (EBS) stock has given a buy signal, with rising moving average. Stochastic and ADX also given a buy signal. Emergent BioSolutions Inc. com (EBS) announced on 10/1/08, it will receive between $364 million and $404 million for new contracts to supply the U.S. government with anthrax vaccines. Emergent BioSolutions Inc. com (EBS) is a Biotechnology company. As per technical analysis, stock analysis and fundamentally this stock looks good candidate for portfolio investment. Emergent BioSolutions Inc. com stock you can consider for Stock Market Investment, Swing Trading, Stock trading, Stock Investing, Day trading, Stock picks, Breakout Stocks. Due to stock market and economic condition keep tight stop loss on all position. You can buy this stock near $18
Emergent BioSolutions to Webcast Presentation at the 6th Annual Southwestern Showcase Investor Conference on November 20, 2008 (Business Wire)
ROCKVILLE, Md.----Emergent BioSolutions Inc. announced today that the company will be webcasting its presentation at the 6th Annual Southwestern Showcase Investor Conference scheduled for Thursday, November 20, 2008 at 1:40 pm Central.(Tue, 18 Nov 2008 21:44:00 Etc/GMT)
Emergent BioSolutions Files Shelf Registration (at Seeking Alpha)
(Thu, 13 Nov 2008 23:16:22 Etc/GMT)
Emergent BioSolutions Files Universal Shelf Registration Statement (Business Wire)
ROCKVILLE, Md.----Emergent BioSolutions Inc. announced today that it has filed with the U.S. Securities and Exchange Commission a universal shelf registration statement which, when declared effective, will permit the company to issue up to an aggregate of $100 million of common stock, preferred stock, debt securities and warrants.(Thu, 13 Nov 2008 00:20:00 Etc/GMT)
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Results of Oper